BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15067195)

  • 1. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Ito K; Kasanuki N; Koga T
    J Atheroscler Thromb; 2004; 11(1):22-8. PubMed ID: 15067195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin sodium, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases serum total cholesterol in Japanese White rabbits by two different mechanisms.
    Miyazaki A; Koga T
    Atherosclerosis; 2002 Jun; 162(2):299-306. PubMed ID: 11996949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.
    Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Dean J; Boulton AJ
    Diabetes; 1995 Apr; 44(4):460-5. PubMed ID: 7698516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Ito T
    Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.
    Fujioka T; Nara F; Tsujita Y; Fukushige J; Fukami M; Kuroda M
    Biochim Biophys Acta; 1995 Jan; 1254(1):7-12. PubMed ID: 7811749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unidirectional transfer in vivo of high-density lipoprotein cholesteryl esters to lower-density lipoproteins in the pig, an animal species without plasma cholesteryl ester transfer activity.
    Terpstra AH; Stucchi AF; Foxall TL; Shwaery GT; Vespa DB; Nicolosi RJ
    Metabolism; 1993 Dec; 42(12):1524-30. PubMed ID: 8246765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients.
    Hillebrant CG; Axelson M; Björkhem I; Wang FH; Nyberg B; Einarsson C
    Eur J Clin Invest; 1998 Apr; 28(4):324-8. PubMed ID: 9615912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
    Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
    Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.
    Johns DG; Chen Y; Wang SP; Castro-Perez J; Previs SF; Roddy TP
    Eur J Pharmacol; 2015 Sep; 762():256-62. PubMed ID: 26049012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion.
    Harada LM; Amigo L; Cazita PM; Salerno AG; Rigotti AA; Quintão EC; Oliveira HC
    Atherosclerosis; 2007 Apr; 191(2):313-8. PubMed ID: 16806230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage.
    Kobayashi J; Okamoto H; Otabe M; Bujo H; Saito Y
    Atherosclerosis; 2002 May; 162(1):131-5. PubMed ID: 11947906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.
    Craig WY; Cooper AD
    J Lipid Res; 1988 Mar; 29(3):299-308. PubMed ID: 2837527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
    Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes.
    Tanaka M; Jingami H; Otani H; Cho M; Ueda Y; Arai H; Nagano Y; Doi T; Yokode M; Kita T
    J Biol Chem; 1993 Jun; 268(17):12713-8. PubMed ID: 8509406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductase in rat liver.
    Carrella M; Fong LG; Loguercio C; Del Piano C
    Metabolism; 1999 May; 48(5):618-26. PubMed ID: 10337863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
    Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
    Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits.
    Goldberg DI; Beltz WF; Pittman RC
    J Clin Invest; 1991 Jan; 87(1):331-46. PubMed ID: 1985105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells.
    Fluiter K; van Berkel TJ
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):515-9. PubMed ID: 9291126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for extralysosomal hydrolysis of high-density lipoprotein cholesteryl esters in rat hepatoma cells (Fu5AH): a model for delivery of high-density lipoprotein cholesterol.
    DeLamatre JG; Carter RM; Hornick CA
    J Cell Physiol; 1991 Jan; 146(1):18-24. PubMed ID: 1990016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.